Bülent Eser

2.5k total citations
119 papers, 1.9k citations indexed

About

Bülent Eser is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Bülent Eser has authored 119 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 27 papers in Oncology and 26 papers in Epidemiology. Recurrent topics in Bülent Eser's work include Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (12 papers) and Hemoglobinopathies and Related Disorders (11 papers). Bülent Eser is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (12 papers) and Hemoglobinopathies and Related Disorders (11 papers). Bülent Eser collaborates with scholars based in Türkiye, Cyprus and United States. Bülent Eser's co-authors include Ali Ünal, Mustafa Çetın, Leylagül Kaynar, Fevzi Altuntaş, Özlem Er, Mustafa Altınbaş, Metin Özkan, İ̇smail Sarı, H.Ş. Çoşkun and Serdar Soyuer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bülent Eser

117 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bülent Eser Türkiye 23 543 317 267 251 231 119 1.9k
Carlo Bonfanti Italy 24 502 0.9× 430 1.4× 227 0.9× 144 0.6× 153 0.7× 90 1.8k
Antonio Giulivi Canada 25 442 0.8× 788 2.5× 201 0.8× 80 0.3× 121 0.5× 88 2.2k
Marjory B. Brooks United States 28 1.1k 2.0× 266 0.8× 518 1.9× 88 0.4× 93 0.4× 144 2.5k
Robert Goggs United States 29 558 1.0× 275 0.9× 326 1.2× 83 0.3× 48 0.2× 94 2.0k
Craig S. Kitchens United States 29 810 1.5× 172 0.5× 323 1.2× 65 0.3× 289 1.3× 91 2.4k
Jeanet M. Kemmeren Netherlands 21 351 0.6× 300 0.9× 242 0.9× 59 0.2× 79 0.3× 47 2.0k
Reto A. Schuepbach Switzerland 25 871 1.6× 361 1.1× 83 0.3× 173 0.7× 468 2.0× 101 2.8k
Michael Schwameis Austria 23 264 0.5× 309 1.0× 126 0.5× 63 0.3× 74 0.3× 96 1.6k
Margot S. Kruskall United States 28 1.1k 1.9× 704 2.2× 88 0.3× 76 0.3× 368 1.6× 65 3.1k
Ahmet Faik Öner Türkiye 21 339 0.6× 714 2.3× 51 0.2× 122 0.5× 122 0.5× 99 1.6k

Countries citing papers authored by Bülent Eser

Since Specialization
Citations

This map shows the geographic impact of Bülent Eser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bülent Eser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bülent Eser more than expected).

Fields of papers citing papers by Bülent Eser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bülent Eser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bülent Eser. The network helps show where Bülent Eser may publish in the future.

Co-authorship network of co-authors of Bülent Eser

This figure shows the co-authorship network connecting the top 25 collaborators of Bülent Eser. A scholar is included among the top collaborators of Bülent Eser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bülent Eser. Bülent Eser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dal, Mehmet Sinan, Tuğçe Nur Yiğenoğlu, Semih Başçı, et al.. (2023). Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey. Journal of Chemotherapy. 35(6). 563–569. 2 indexed citations
2.
Muhtaroğlu, Sabahattin, Mustafa Yavuz Köker, Nazan Sarper, et al.. (2021). Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of thirty-two Turkish patients with Glanzmann thrombasthenia: a multicenter experience. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(4). 2135–2141. 5 indexed citations
3.
Yeral, Mahmut, Can Boğa, Ali Ünal, et al.. (2020). A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity. Clinical Lymphoma Myeloma & Leukemia. 20(10). 652–660. 4 indexed citations
4.
Aydoğdu, İsmet, Mehmet Şencan, Ali Kaya, et al.. (2017). Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematological Oncology. 36(1). 116–120. 4 indexed citations
6.
Keklık, Muzaffer, Serdar Şıvgın, Kemal Denız, et al.. (2013). Coincidence of three solid tumors in a patient with multiple myeloma. Chinese Medical Journal. 126(6). 1186–1187. 2 indexed citations
7.
Baldane, Süleyman, Muzaffer Keklık, Leylagül Kaynar, et al.. (2013). The Impact of Pretransplant Hypoalbuminemia on Survival in patients With Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Nutritional Problem?. Transplantation Proceedings. 45(9). 3371–3374. 11 indexed citations
8.
Şıvgın, Serdar, Bülent Eser, Leylagül Kaynar, et al.. (2013). Encephalitozoon intestinalis: A Rare Cause of Diarrhea in an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipient Complicated by Albendazole-Related Hepatotoxicity. SHILAP Revista de lepidopterología. 30(2). 204–208. 5 indexed citations
9.
Metan, Gökhan, et al.. (2011). Can bacteraemia lead to false positive results in 1,3-beta-d-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections. Revista Iberoamericana de Micología. 29(3). 169–171. 25 indexed citations
10.
Metan, Gökhan, Ayşe Nedret Koç, Leylagül Kaynar, et al.. (2011). What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?. Scandinavian Journal of Infectious Diseases. 44(5). 330–336. 19 indexed citations
11.
Baldane, Süleyman, Leylagül Kaynar, Fatih Kurnaz, et al.. (2011). Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation. Neoplasma. 59(2). 183–190. 25 indexed citations
12.
Tokgöz, Bülent, İsmail Koçyiğit, Bülent Eser, et al.. (2010). Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and relationship with the quantity of transplanted cells. Renal Failure. 32(5). 547–554. 10 indexed citations
13.
Eser, Bülent, Fatih Kurnaz, Leylagül Kaynar, et al.. (2010). Are university students a favorable target group for blood donation campaigns?. Turkish Journal of Hematology. 27(4). 275–281. 9 indexed citations
14.
Kaynar, Leylagül, Fevzi Altuntaş, Ismet Aydogdu, et al.. (2008). Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study. Transfusion and Apheresis Science. 38(2). 109–115. 48 indexed citations
15.
Eser, Bülent, Muhammet Güven, Ali Ünal, et al.. (2005). The Role of Plasma Exchange in HELLP Syndrome. Clinical and Applied Thrombosis/Hemostasis. 11(2). 211–217. 61 indexed citations
16.
Er, Özlem, H.Ş. Çoşkun, Mustafa Altınbaş, et al.. (2004). Meropenem +/− Granulocyte Colony Stimulating Factor in the Treatment of Febrile Neutropenic Patients with Cancer: Prospective Randomized Study. Journal of Chemotherapy. 16(3). 288–292. 1 indexed citations
17.
Altınbaş, Mustafa, H.Ş. Çoşkun, Özlem Er, et al.. (2004). A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer. Journal of Thrombosis and Haemostasis. 2(8). 1266–1271. 367 indexed citations
18.
Altınbaş, Mustafa, Özlem Er, Metin Özkan, et al.. (2004). Ifosfamide, Mesna, and Interferon-Alpha2A Combination Chemoimmunotherapy in Malignant Mesothelioma: Results of a Single Center in Central Anatolia. Medical Oncology. 21(4). 359–366. 3 indexed citations
19.
Güven, Muhammet, Murat Sungur, Fatih Tanrıverdi, Bülent Eser, & Zeynep Kekeç. (2002). Evaluation of the Patients with Acute Intoxication. DergiPark (Istanbul University). 12 indexed citations
20.
Yıldız, Orhan, et al.. (2000). Febril nötropenik bir hastada Listeria monocytogenes'e bağlı sepsis. 14(4). 547–550.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026